Conference Overview
The right people – in the right place – at the right time
Economic turmoil, declining R&D productivity and patent expirations, increased competition from generics and biosimilars, the expected impact of the US healthcare reforms, the rapid growth of emerging economies and regulatory caution are all providing challenges that for some may be insurmountable. Yet for those businesses far sighted enough, these changes are presenting new opportunities on which they can capitalise.
So what must the industry do to capitalise on them?
Join us in Monte Carlo at the exclusive, by invitation only, 2010 Biopharmaceutical Conference in Europe to be part of the debate and gain new insights for your business future.
